VEGFA and breast carcinoma: We were able to demonstrate that treatment with the oncolytic vaccinia virus GLV-5b451 harbouring the gene for the anti-VEGF scAb GLAF-2 significantly reduced the growth of feline mammary carcinoma xenografts predominantly by oncolysis and inhibited tumor angiogenesis simultaneously.